Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1033.00 | 1069.00 | 0.9663 | 0.9285 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2330.00 | 2583.50 | 0.9019 | 0.8197 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2484.00 | 2583.50 | 0.9615 | 0.9294 | |
| SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 1250.00 | 1210.88 | 1022.00 | 2583.50 | 0.3956 | -0.1437 |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2746.00 | 2583.50 | 1.0629 | 1.1148 | |
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 1250.00 | 1210.88 | 2739.00 | 2583.50 | 1.0602 | 1.1098 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 3 | 1250.00 | 1210.88 | 2725.00 | 2583.50 | 1.0548 | 1.1000 |
| SK-BR-3 | Nilotinib | 10 | uM | 3 | 1250.00 | 1210.88 | 1225.00 | 2583.50 | 0.4742 | 0.0107 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 3 | 1250.00 | 1210.88 | 1202.00 | 2583.50 | 0.4653 | -0.0067 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 1250.00 | 1210.88 | 936.00 | 2583.50 | 0.3623 | -0.2098 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 1250.00 | 1210.88 | 2403.00 | 2583.50 | 0.9301 | 0.8718 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 1250.00 | 1210.88 | 2934.00 | 2583.50 | 1.1357 | 1.2468 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 3 | 1250.00 | 1210.88 | 1288.00 | 2583.50 | 0.4986 | 0.0581 |
| SK-BR-3 | Nilotinib | 1 | uM | 3 | 1250.00 | 1210.88 | 2722.00 | 2583.50 | 1.0536 | 1.0979 |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2646.00 | 2583.50 | 1.0242 | 1.0442 | |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 1250.00 | 1210.88 | 2451.00 | 2583.50 | 0.9487 | 0.9060 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 1250.00 | 1210.88 | 2478.00 | 2583.50 | 0.9592 | 0.9252 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 3 | 1250.00 | 1210.88 | 2543.00 | 2583.50 | 0.9843 | 0.9713 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 1250.00 | 1210.88 | 1264.00 | 2583.50 | 0.4893 | 0.0401 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 3 | 1250.00 | 1210.88 | 1715.00 | 2583.50 | 0.6638 | 0.3749 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 1250.00 | 1210.88 | 2576.00 | 2583.50 | 0.9971 | 0.9947 |
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 1250.00 | 1210.88 | 2499.00 | 2583.50 | 0.9673 | 0.9401 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 3 | 1250.00 | 1210.88 | 2400.00 | 2583.50 | 0.9290 | 0.8697 |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2438.00 | 2583.50 | 0.9437 | 0.8967 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 1951.00 | 2583.50 | 0.7552 | 0.5470 |